A Phase 1 Study to Evaluate Pregabalin and Acetaminophen in Healthy Volunteers
Status:
Completed
Trial end date:
2020-07-22
Target enrollment:
Participant gender:
Summary
This is a Phase 1, randomized, double-blind, placebo-controlled, single and multiple
ascending dose study to determine a maximum tolerated dose of IV PGB and to evaluate the
safety, tolerability, and PK of an admixture of IV PGB and a fixed dose of 1300 mg IV APAP in
healthy adult volunteers.